Investors Investors

Investors

Emmaus Medical, a wholly-owned subsidiary of Emmaus Life Sciences, is engaged in the discovery, development, and commercialization of innovative and cost-effective treatments and therapies for rare diseases.  Currently, the primary focus of our business is the late-stage development -- presently in Phase III clinical trials with the FDA – of the amino acid L-glutamine as a prescription drug for the treatment of Sickle Cell Disease.

We are also engaged, to a lesser extent, in the marketing and sale of NutreStore® [L-glutamine powder for oral solution] as a treatment for short bowel syndrome. 

Over time, we plan to expand our business to include developing and marketing products to treat more common diseases.  

 

SEC FILINGS

To access our filings with the U.S. Securities and Exchange Commission, please click here

Filings can be located under EMMAUS LIFE SCIENCES, INC. CIK#: 0001420031  

 

Insider Transactions

To view our insider transactions, please click here

 

XBRL Filings and Interactive Data

To view our first quarter 2014 interactive data, please click here.  To download the XBRL filing, please click here.

To view our year end 2013 interactive data, please click here.  To download the XBRL filing, please click here.

To view our amended third quarter 2013 interactive data, please click here.  To download the XBRL filing, please click here.

To view our third quarter 2013 interactive data, please click here.  To download the XBRL filing, please click here.

To view our second quarter 2013 interactive data, please click here.  To download the XBRL filing, please click here.

To view our first quarter 2013 interactive data, please click here.  To download the XBRL filing, please click here.

To view our year end 2012 interactive data, please click here.  To download the XBRL filing, please click here.

To view our third quarter 2012 interactive data, please click here.  To download the XBRL filing, please click here.

To view our second quarter 2012 interactive data, please click here.  To download the XBRL filing, please click here.

To view our first quarter 2012 interactive data, please click here.  To download the XBRL filing, please click here.

To view our year end 2011 interactive data, please click here.  To download the XBRL filing, please click here.

To view our amended second quarter 2011 interactive data, please click here.  To download the XBRL filing, please click here.

To view our amended third quarter 2011 interactive data, please click here.  To download the XBRL filing, please click here.

To view our amended second quarter 2011 interactive data, please click here.  To download the XBRL filing, please click here.

To view our third quarter 2011 interactive data, please click here.  To download the XBRL filing, please click here.

To view our amended second quarter 2011 interactive data, please click here.  To download the XBRL filing, please click here.

To view our second quarter 2011 interactive data, please click here.  To download the XBRL filing, please click here.